Director in Apollomics (APLM) reports 2,000 restricted stock units on Form 3

Rhea-AI Filing Summary

Apollomics Inc. director TSAI HSIEN-SHU reported an initial holding of restricted stock units that are linked to the company’s Class A Ordinary Shares. The position covers restricted stock units tied to 2,000 underlying Class A Ordinary Shares held directly.

According to the footnotes, these restricted stock units vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares scheduled to vest on each of March 15, 2026, June 15, 2026 and September 15, 2026. Each unit represents a contingent right to receive one Class A Ordinary Share.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

TSAI HSIEN-SHU

(Last) (First) (Middle)

989 E HILLSDALE BLVD, SUITE 220

(Street)

FOSTER CITY 94404

(City) (State) (Zip)

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Class A Ordinary Shares	2,000	(2)	D

Explanation of Responses:

1. The restricted stock units were vested with respect to 500 shares upon grant on February 9, 2026, with an additional 500 shares vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026.

2. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.

Remarks:

This Initial Statement of Beneficial Ownership is being filed in connection with the enactment of the Holding Foreign Insiders Accountable Act and the rules and regulations adopted in association therewith.

	/s/ Tsai, Hsien-Shu	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What insider position did TSAI HSIEN-SHU report in Apollomics (APLM) Form 3?

TSAI HSIEN-SHU reported holding restricted stock units tied to 2,000 Apollomics Class A Ordinary Shares. These units reflect equity-based compensation and are held directly, giving the director contingent rights to receive company shares as they vest over time.

How many Apollomics (APLM) shares underlie the reported restricted stock units?

The filing shows restricted stock units linked to 2,000 underlying Class A Ordinary Shares. Each unit equals a contingent right to receive one share, so the full award represents potential ownership of 2,000 shares once all vesting conditions are satisfied.

What is the vesting schedule of the Apollomics (APLM) restricted stock units?

The units vested with respect to 500 shares on February 9, 2026, the grant date. Additional tranches of 500 shares vest on March 15, 2026, June 15, 2026 and September 15, 2026, creating four equal installments across the vesting period.

Does each Apollomics (APLM) restricted stock unit convert into one share?

Yes. The footnotes state that each restricted stock unit represents a contingent right to receive one Class A Ordinary Share. This means 2,000 units correspond to a potential total of 2,000 shares if all vesting conditions are met.

Is the Apollomics (APLM) Form 3 filing a buy or sell transaction?

The Form 3 reflects an initial statement of beneficial ownership, not an open-market buy or sell. It records an existing equity award of restricted stock units and their vesting schedule rather than a new purchase or sale of Apollomics shares.

What type of security is reported in the Apollomics (APLM) Form 3?

The security reported is restricted stock units, each linked to one Class A Ordinary Share. These units are a form of equity compensation that convert into actual shares over time, according to the specified vesting dates in the award’s terms.